S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Log in
NASDAQ:LOAC

Longevity Acquisition Stock Forecast, Price & News

$10.95
-0.38 (-3.35 %)
(As of 01/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.63
Now: $10.95
$11.43
50-Day Range
$10.73
MA: $12.03
$13.80
52-Week Range
$10.24
Now: $10.95
$19.25
Volume109,666 shs
Average Volume126,043 shs
Market Capitalization$28.75 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.01
Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.

MarketRank

Overall MarketRank

0.33 out of 5 stars

Unclassified Sector

69th out of 247 stocks

Holding & Other Investment Offices Industry

68th out of 204 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
Current SymbolNASDAQ:LOAC
CUSIPN/A
CIKN/A
WebN/A
Phone86 21 6083 2028
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.92 per share

Profitability

Net Income$-290,000.00

Miscellaneous

Market Cap$28.75 million
Next Earnings Date4/29/2021 (Estimated)
OptionableNot Optionable
$10.95
-0.38 (-3.35 %)
(As of 01/27/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LOAC News and Ratings via Email

Sign-up to receive the latest news and ratings for LOAC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Longevity Acquisition (NASDAQ:LOAC) Frequently Asked Questions

What stocks does MarketBeat like better than Longevity Acquisition?

Wall Street analysts have given Longevity Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Longevity Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Longevity Acquisition's next earnings date?

Longevity Acquisition is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Longevity Acquisition
.

Who are some of Longevity Acquisition's key competitors?

Who are Longevity Acquisition's key executives?

Longevity Acquisition's management team includes the following people:
  • Mr. Matthew Chen, Chairman & CFO (Age 49)
  • Mr. Alex Lyamport, CEO & Director (Age 50)

What is Longevity Acquisition's stock symbol?

Longevity Acquisition trades on the NASDAQ under the ticker symbol "LOAC."

How do I buy shares of Longevity Acquisition?

Shares of LOAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Longevity Acquisition's stock price today?

One share of LOAC stock can currently be purchased for approximately $10.95.

How big of a company is Longevity Acquisition?

Longevity Acquisition has a market capitalization of $28.75 million.

How can I contact Longevity Acquisition?

Longevity Acquisition's mailing address is YONGDA INTERNATIONAL TOWER NO. 2277 LONGEVITY ROAD PUDONG DISTRICT, SHANGHAI F4, 20000. The company can be reached via phone at 86 21 6083 2028.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.